Celularity Inc. cash flow to debt ratio of -32.41% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Celularity Inc.'s free cash flow has decreased 101.98% from $-6.56M last year to $-13.25M, signaling decreasing performance

Celularity Inc.'s debt to equity ratio is -1.07, signaling that the company spent its equity and risk bankruptcy.

Celularity Inc.'s debt to equity ratio is -1.07, signaling that the company spent its equity and risk bankruptcy.

Celularity Inc. has negative EBITDA, making leverage ratio unreliable

Celularity Inc.'s interest coverage ratio is -9.08, which means that the company struggles to meet interest obligations, signaling financial risk.

Celularity Inc.'s profit margin has decreased (223.52%) in the last year from -106.77% to -345.44%, signaling decreasing performance

Celularity Inc.'s short-term liabilities of $80.76M exceed its short-term assets of $12.32M, signaling financial risk

Celularity Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Celularity Inc.'s return on equity of 411.46%, is higher than 15.00%, indicating good performance

Celularity Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Celularity Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Celularity Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Celularity Inc. has negative free cash flow, indicating cash burn

Celularity Inc.'s yearly earnings has decreased 58.57% since last year from $-57.89M to $-91.80M, signaling decreasing performance

Celularity Inc.'s yearly revenue has decreased 51.03% since last year from $54.22M to $26.55M, signaling decreasing performance

ROIC -151.11% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Celularity Inc.'s 3-year revenue CAGR of 13.88% is positive, indicating growing revenue over the past 3 years

Celularity Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Celularity Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Celularity Inc. has insufficient data to evaluate this check.

Celularity Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Celularity Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Celularity Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Celularity Inc. is overvalued relative to its fair value price of -46.35 based on Earnings Fair Value model

Celularity Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Celularity Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Celularity Inc. has a price-to-sales ratio of 0.66x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue